Home | Working Groups publications

Working Groups publications

10 / 103 Ergebnisse gefunden

Clinical Management of Peripheral Arterial Disease in Chronic Kidney Disease – a comprehensive review from the European Renal Association CKD-MBD Working Group

April 07, 2025

CKD-MBD WG

Very low SBP targets and the boom-and-bust cycle of benefit and adverse kidney events

März 07, 2025

EuReCa-M WG

Kidney expert consultation and the outcomes of in hospital acute kidney injury

Februar 28, 2025

ERAKI WG

Global access to management of primary hyperoxaluria: a survey on behalf of OxalEurope, G&K working group of the ERA, and ESPN

Februar 21, 2025

G&K WG

The impact of the new WHO Classification of renal cell carcinoma on the diagnosis of hereditary leiomyomatosis and renal cell carcinoma

Februar 20, 2025

G&K WG

Disease-modifying anti-nephropathic drugs (DMANDs) – A definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)

Februar 08, 2025

IWG WG

Haemodiafiltration versus high-flux haemodialysis – a Consensus Statement from the EuDial Working Group of the ERA

Februar 06, 2025

EuDial WG

The role of nutritional vitamin D in CKD-MBD in children and adults with CKD, on dialysis and after kidney transplantation – a European consensus statement

Januar 28, 2025

CKD-MBD WG

Nephrectomy in Autosomal Dominant Polycystic Kidney Disease: A consensus statement of the ERA Genes & Kidney Working Group

Januar 23, 2025

G&K WG

DEFENDER Trial: Dapagliflozin for Critically Ill Patients with Acute Organ Dysfunction – Implications for clinicians

Januar 15, 2025

ERAKI WG

Mehr laden

Werden Sie Mitglied der ERA Working Groups oder erneuern Sie Ihr Interesse

Entdecke die Geschichten unserer Mitglieder

Entdecke die Initiativen bei #ERA25

ERA-Stipendienbewerbungen sind jetzt offen

Zugang zu ERA E-Learning

Probieren Sie die ‚Taube‘ Knödel

Webcast verfügbar!

Webcast verfügbar!

Suggestions

Working Groups publications

{%TITLE%}

{%TITLE%}

Clinical Management of Peripheral Arterial Disease in Chronic Kidney Disease – a comprehensive review from the European Renal Association CKD-MBD Working Group

Very low SBP targets and the boom-and-bust cycle of benefit and adverse kidney events

Kidney expert consultation and the outcomes of in hospital acute kidney injury

Global access to management of primary hyperoxaluria: a survey on behalf of OxalEurope, G&K working group of the ERA, and ESPN

The impact of the new WHO Classification of renal cell carcinoma on the diagnosis of hereditary leiomyomatosis and renal cell carcinoma

Disease-modifying anti-nephropathic drugs (DMANDs) – A definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)

Haemodiafiltration versus high-flux haemodialysis – a Consensus Statement from the EuDial Working Group of the ERA

The role of nutritional vitamin D in CKD-MBD in children and adults with CKD, on dialysis and after kidney transplantation – a European consensus statement

Nephrectomy in Autosomal Dominant Polycystic Kidney Disease: A consensus statement of the ERA Genes & Kidney Working Group

DEFENDER Trial: Dapagliflozin for Critically Ill Patients with Acute Organ Dysfunction – Implications for clinicians